This enduring activity will focus on improving clinicians’ knowledge and competence in the impact of HPV vaccination in mid-adults and strategies to appropriately incorporate HPV vaccination in mid-adults. As a result of this educational activity, learners should be better able to: 1. Recognize the rationale for HPV vaccination in appropriate adults ages 27-45 years old 2. Review the clinical impact of HPV vaccination in appropriate adults ages 27-45 years old 3. Outline patient-centered strategies to appropriately incorporate HPV vaccination into prevention plans for eligible adults ages 27-45 years old. Insights from the learner target audience were collected and used to help define the topics discussed making this a practical, highly clinically-relevant educational opportunity. Content is presented via 5 video-based sessions in a fast-paced microburst learning format. Features include downloadable slides and podcast.
- Provider:Answers in CME Inc. (AiCME)
- Activity Link: https://www.answersincme.com/VNG
- Start Date: 2024-11-20 06:00:00
- End Date: 2024-11-20 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Merck (Any division) - Amount: 176797.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Competence, Learner Knowledge
- Provider Ship: Directly Provided
- Registration: Open to all